Technical Analysis for TOCA - Tocagen Inc.

Grade Last Price % Change Price Change
grade F 8.88 0.00% 0.00
TOCA closed unchanged on Friday, May 17, 2019, on 80 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TOCA trend table...

Date Alert Name Type % Chg
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 0.34%
Doji - Bullish? Reversal 0.34%
Stochastic Reached Oversold Weakness 0.34%
Oversold Stochastic Weakness 0.34%
Calm After Storm Range Contraction -0.56%
Inside Day Range Contraction -0.56%
MACD Bearish Signal Line Cross Bearish 0.68%

Older signals for TOCA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells. Its lead product candidates are vocimagene amiretrorepvec (Toca 511) and flucytosine extended release (Toca FC). Toca 511 is an investigational injectable retroviral replicating vector (RRV) that encodes a prodrug activator enzyme, cytosine deaminase (CD). Toca FC is an investigational extended-release version of 5-fluorocytosine (5-FC), a prodrug that is inactive as an anti-cancer drug. As of February, 2017, Tocagen has completed enrollment of the Phase II portion with 187 patients.
Biotechnology Cancer Life Sciences Biology Gene Therapy Applied Genetics
Is TOCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.8
52 Week Low 6.47
Average Volume 190,583
200-Day Moving Average 10.6306
50-Day Moving Average 10.0158
20-Day Moving Average 9.4585
10-Day Moving Average 9.406
Average True Range 0.5564
ADX 15.09
+DI 22.6788
-DI 24.5673
Chandelier Exit (Long, 3 ATRs ) 9.2108
Chandelier Exit (Short, 3 ATRs ) 10.0192
Upper Bollinger Band 10.7664
Lower Bollinger Band 8.1506
Percent B (%b) 0.28
BandWidth 27.655548
MACD Line -0.2817
MACD Signal Line -0.2031
MACD Histogram -0.0786
Fundamentals Value
Market Cap 175.91 Million
Num Shares 19.8 Million
EPS -6.18
Price-to-Earnings (P/E) Ratio -1.44
Price-to-Sales 4252.02
Price-to-Book 2.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.72
Resistance 3 (R3) 9.76 9.51 9.58
Resistance 2 (R2) 9.51 9.30 9.50 9.53
Resistance 1 (R1) 9.20 9.17 9.36 9.16 9.49
Pivot Point 8.95 8.95 9.03 8.94 8.95
Support 1 (S1) 8.64 8.74 8.80 8.60 8.27
Support 2 (S2) 8.39 8.61 8.38 8.23
Support 3 (S3) 8.08 8.39 8.18
Support 4 (S4) 8.04